{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:42:47Z","timestamp":1767148967315,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.purol.2018.08.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}},{"DOI":"10.1016\/j.purol.2019.02.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"am","delay-in-days":709,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.purol.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T08:17:17Z","timestamp":1566548237000},"page":"R149-R166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S1","title":["Recommandations fran\u00e7aises du Comit\u00e9 de Canc\u00e9rologie de l\u2019AFU \u2013\u00a0Actualisation 2018\u20132020\u00a0: tumeurs germinales du testicule"],"prefix":"10.1016","volume":"28","author":[{"given":"T.","family":"Murez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fl\u00e9chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-H.","family":"Savoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Camparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Morel-Journel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e8be","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"M\u00e9jean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urolonc.2012.12.002","article-title":"Dieckmann K-P. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing","volume":"32","author":"Ruf","year":"2014","journal-title":"Urol Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.purol.2019.01.009_bib0380","first-page":"S57","article-title":"Incidence and mortality of urological cancers in 2012\u00a0in France","volume":"23","author":"R\u00e9billard","year":"2013","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"issue":"4","key":"10.1016\/j.purol.2019.01.009_bib0385","first-page":"831","article-title":"Testicular cancer incidence to rise by 25\u00a0% by 2025\u00a0in Europe? Model-based predictions in 40\u00a0countries using population-based registry data","volume":"50","author":"Le Cornet","year":"2014","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"9\u00a0Pt B","key":"10.1016\/j.purol.2019.01.009_bib0390","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1464-410X.2009.08854.x","article-title":"Epidemiology of testicular cancer","volume":"104","author":"Manecksha","year":"2009","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.purol.2019.01.009_bib0395","first-page":"1644","article-title":"Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970\u00a0and 2011","volume":"26","author":"Callaghan","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol."},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0400","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00330-014-3437-x","article-title":"Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee","volume":"25","author":"Richenberg","year":"2015","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.purol.2019.01.009_bib0405","first-page":"S1","article-title":"Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005\u00a0and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association","volume":"21","author":"Miki","year":"2014","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur Urol"},{"issue":"9\u00a0Pt B","key":"10.1016\/j.purol.2019.01.009_bib0415","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1464-410X.2009.08856.x","article-title":"Contemporary radiological imaging of testicular cancer","volume":"104","author":"Hilton","year":"2009","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000338771","article-title":"Testicular tumor ultrasound characteristics and association with histopathology","volume":"89","author":"McDonald","year":"2012","journal-title":"Urol Int"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0425","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2214\/AJR.12.10319","article-title":"Testicular cancer: what the radiologist needs to know","volume":"200","author":"Kreydin","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.purol.2019.01.009_bib0430","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.crad.2008.10.011","article-title":"Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours","volume":"64","author":"Sohaib","year":"2009","journal-title":"Clin Radiol"},{"issue":"11","key":"10.1016\/j.purol.2019.01.009_bib0435","first-page":"887","article-title":"Brain metastases from testicular germ cell tumors: a retrospective analysis","volume":"16","author":"Nonomura","year":"2009","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0440","first-page":"1687","article-title":"Role of frozen section examination in the management of testicular nodules: a useful procedure to identify benign lesions","volume":"11","author":"Bozzini","year":"2014","journal-title":"Urol J"},{"issue":"4\u00a0Pt 2","key":"10.1016\/j.purol.2019.01.009_bib0445","first-page":"e7","article-title":"Testicular biopsy for early cancer detection--objectives, technique and controversies","volume":"34","author":"Dieckmann","year":"2011","journal-title":"Int J Androl"},{"key":"10.1016\/j.purol.2019.01.009_bib0450","first-page":"407","article-title":"Role of chemotherapy prior to orchiectomy in metastatic testicular cancer-is testis really a sanctuary site?","volume":"8","author":"Reddy","year":"2014","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0455","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016\u00a0WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0460","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/PAS.0000000000000844","article-title":"Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations","volume":"41","author":"Verrill","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.purol.2019.01.009_bib0465","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"issue":"22","key":"10.1016\/j.purol.2019.01.009_bib0470","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.purol.2019.01.009_bib0480","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","article-title":"Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)","volume":"27","author":"Tandstad","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"8","key":"10.1016\/j.purol.2019.01.009_bib0485","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial","volume":"21","author":"Albers","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0490","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell, cancers., International Germ Cell Cancer Collaborative Group","volume":"15","year":"1997","journal-title":"J Clin, Oncol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0495","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2164\/jandrol.112.016592","article-title":"The semen quality of 1158\u00a0men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network","volume":"33","author":"Rives","year":"2012","journal-title":"J Androl."},{"issue":"30","key":"10.1016\/j.purol.2019.01.009_bib0500","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0505","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.fertnstert.2016.11.015","article-title":"Sperm aneuploidy after testicular cancer treatment: data from a prospective multicenter study performed within the French Centre d\u2019\u00c9tude et de Conservation des Oeufs et du Sperme network","volume":"107","author":"Rives","year":"2017","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0510","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/annonc\/mdi175","article-title":"Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review","volume":"16","author":"Hoei-Hansen","year":"2005","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0515","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.bjc.6600771","article-title":"Radiotherapy with 16Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group","volume":"88","author":"Classen","year":"2003","journal-title":"Br J Cancer."},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0520","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.critrevonc.2007.04.014","article-title":"A comprehensive systematic review of testicular germ cell tumor surveillance","volume":"64","author":"Groll","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0525","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2010.30.1044","article-title":"Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group","volume":"29","author":"Tandstad","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0530","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.eururo.2017.12.030","article-title":"Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary","volume":"73","author":"Pierorazio","year":"2018","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0535","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","article-title":"A nationwide cohort study of stage I seminoma patients followed on a surveillance program","volume":"66","author":"Mortensen","year":"2014","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.purol.2019.01.009_bib0540","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","article-title":"Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982\u00a0study (ISRCTN27163214)","volume":"29","author":"Oliver","year":"2011","journal-title":"J Clin Oncol."},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0545","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","article-title":"Randomized trial of 30\u00a0versus 20Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18. European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)","volume":"23","author":"Jones","year":"2005","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.purol.2019.01.009_bib0550","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/cncr.28086","article-title":"Outcomes in stage I testicular seminoma: a population-based study of 9193\u00a0patients","volume":"119","author":"Beard","year":"2013","journal-title":"Cancer"},{"issue":"34","key":"10.1016\/j.purol.2019.01.009_bib0555","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0560","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.purol.2019.01.009_bib0565","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.1996.14.4.1106","article-title":"Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report","volume":"14","author":"Cullen","year":"1996","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.purol.2019.01.009_bib0570","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2007.12.0899","volume":"26","author":"Albers","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.purol.2019.01.009_bib0575","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/annonc\/mdu375","article-title":"One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group","volume":"25","author":"Tandstad","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0580","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.eururo.2010.08.032","article-title":"Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence","volume":"58","author":"Nicolai","year":"2010","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0585","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.2003.06.065","article-title":"Radiotherapy for stages IIA\/B testicular seminoma: final report of a prospective multicenter clinical trial","volume":"21","author":"Classen","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.purol.2019.01.009_bib0590","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/annonc\/mdu447","article-title":"Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes","volume":"26","author":"Giannatempo","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0595","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.eururo.2013.09.004","article-title":"A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99\u00a0multicenter prospective study","volume":"65","author":"Fizazi","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2019.01.009_bib0600","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/annonc\/mdm062","article-title":"Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)","volume":"18","author":"Culine","year":"2007","journal-title":"Ann Oncol"},{"issue":"35","key":"10.1016\/j.purol.2019.01.009_bib0605","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1200\/JCO.2007.12.0808","article-title":"Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer","volume":"25","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0610","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2004.07.178","article-title":"Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy","volume":"22","author":"Kondagunta","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0615","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.4528","article-title":"Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors","volume":"25","author":"Motzer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.purol.2019.01.009_bib0620","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S1470-2045(14)70490-5","article-title":"Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial","volume":"15","author":"Fizazi","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.purol.2019.01.009_bib0625","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ejca.2014.01.026","article-title":"Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours","volume":"50","author":"Thibault","year":"2014","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0630","first-page":"261","article-title":"Evaluation of lymph nodes with RECIST 1.1","volume":"45","author":"Schwartz","year":"2009","journal-title":"Eur J Cancer Oxf Engl 190"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0635","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ucl.2015.04.007","article-title":"The Role of Postchemotherapy Surgery in Germ Cell Tumors","volume":"42","author":"Ch\u00e9ry","year":"2015","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0640","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","article-title":"2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial","volume":"22","author":"De Santis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2019.01.009_bib0645","doi-asserted-by":"crossref","first-page":"852681","DOI":"10.1155\/2014\/852681","article-title":"Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis","volume":"2014","author":"Treglia","year":"2014","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0650","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(06)00508-8","article-title":"Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection","volume":"176","author":"Carver","year":"2006","journal-title":"J Urol"},{"issue":"36","key":"10.1016\/j.purol.2019.01.009_bib0655","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1200\/JCO.2008.17.1157","article-title":"[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group","volume":"26","author":"Oechsle","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0660","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdw605","article-title":"Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours","volume":"28","author":"Heidenreich","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0665","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0670","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ucl.2015.04.011","article-title":"Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors","volume":"42","author":"Hu","year":"2015","journal-title":"Urol Clin North Am"},{"issue":"33","key":"10.1016\/j.purol.2019.01.009_bib0675","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1200\/JCO.2009.26.8128","article-title":"Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy","volume":"28","author":"Lorch","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0680","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/0284186X.2011.641507","article-title":"High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)","volume":"51","author":"Haugnes","year":"2012","journal-title":"Acta Oncol Stockh Swed"},{"issue":"16","key":"10.1016\/j.purol.2019.01.009_bib0685","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.2010.32.6678","article-title":"Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database","volume":"29","author":"Lorch","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.purol.2019.01.009_bib0690","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/annonc\/mdu099","article-title":"Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial","volume":"25","author":"Fizazi","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0695","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ucl.2015.04.010","article-title":"Late Relapse of Testicular Germ Cell Tumors","volume":"42","author":"O'Shaughnessy","year":"2015","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.purol.2019.01.009_bib0700","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.purol.2010.02.004","article-title":"Testicular germ cell tumors late relapses","volume":"20","author":"Durand","year":"2010","journal-title":"Progres En Urol J"},{"issue":"11","key":"10.1016\/j.purol.2019.01.009_bib0705","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2006.08.4889","volume":"25","author":"Rustin","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.purol.2019.01.009_bib0710","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/annonc\/mdu518","article-title":"Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15\u00a0years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy","volume":"26","author":"Vidal","year":"2015","journal-title":"Ann Oncol"},{"issue":"9491","key":"10.1016\/j.purol.2019.01.009_bib0715","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"10.1016\/j.purol.2019.01.009_bib0720","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djk111","article-title":"Noncancer causes of death in survivors of testicular cancer","volume":"99","author":"Foss\u00e5","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.purol.2019.01.009_bib0725","first-page":"151","article-title":"Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours","volume":"69","author":"Gizzi","year":"2016","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"1","key":"10.1016\/j.purol.2019.01.009_bib0730","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000471888","article-title":"Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer","volume":"99","author":"Heidegger","year":"2017","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.purol.2019.01.009_bib0735","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2011.37.4025","article-title":"Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer","volume":"30","author":"Sprauten","year":"2012","journal-title":"J Clin Oncol"},{"issue":"30","key":"10.1016\/j.purol.2019.01.009_bib0740","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1016\/j.purol.2019.02.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708719300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708719300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:32:54Z","timestamp":1761114774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708719300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":74,"alternative-id":["S1166708719300272"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2019.01.009","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations fran\u00e7aises du Comit\u00e9 de Canc\u00e9rologie de l\u2019AFU \u2013\u00a0Actualisation 2018\u20132020\u00a0: tumeurs germinales du testicule","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2018.08.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2019.02.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}